1. Home
  2. ATKR vs SUPN Comparison

ATKR vs SUPN Comparison

Compare ATKR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATKR
  • SUPN
  • Stock Information
  • Founded
  • ATKR 1959
  • SUPN 2005
  • Country
  • ATKR United States
  • SUPN United States
  • Employees
  • ATKR N/A
  • SUPN N/A
  • Industry
  • ATKR Industrial Machinery/Components
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATKR Miscellaneous
  • SUPN Health Care
  • Exchange
  • ATKR Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • ATKR 2.2B
  • SUPN 2.0B
  • IPO Year
  • ATKR 2016
  • SUPN 2012
  • Fundamental
  • Price
  • ATKR $57.86
  • SUPN $42.69
  • Analyst Decision
  • ATKR Hold
  • SUPN Buy
  • Analyst Count
  • ATKR 6
  • SUPN 2
  • Target Price
  • ATKR $79.80
  • SUPN $41.00
  • AVG Volume (30 Days)
  • ATKR 766.7K
  • SUPN 1.0M
  • Earning Date
  • ATKR 08-05-2025
  • SUPN 08-05-2025
  • Dividend Yield
  • ATKR 2.28%
  • SUPN N/A
  • EPS Growth
  • ATKR N/A
  • SUPN 1411.53
  • EPS
  • ATKR 3.22
  • SUPN 1.14
  • Revenue
  • ATKR $2,886,664,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • ATKR N/A
  • SUPN N/A
  • Revenue Next Year
  • ATKR $2.01
  • SUPN $15.74
  • P/E Ratio
  • ATKR $17.98
  • SUPN $37.75
  • Revenue Growth
  • ATKR N/A
  • SUPN 5.55
  • 52 Week Low
  • ATKR $49.92
  • SUPN $29.16
  • 52 Week High
  • ATKR $105.28
  • SUPN $43.62
  • Technical
  • Relative Strength Index (RSI)
  • ATKR 33.53
  • SUPN 76.01
  • Support Level
  • ATKR $53.49
  • SUPN $40.26
  • Resistance Level
  • ATKR $59.48
  • SUPN $42.96
  • Average True Range (ATR)
  • ATKR 3.12
  • SUPN 1.78
  • MACD
  • ATKR -1.30
  • SUPN 0.54
  • Stochastic Oscillator
  • ATKR 17.04
  • SUPN 91.38

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: